Claire Collins
Research Subjects
Claire Collins has a total of 83 co-authors. Here are the top co-authors by number of shared publications:
A Berm Udez-Mill
Ghanaian Public University
1 shared publicationAlex Gold
Ghanaian Public University
1 shared publication- Anthony David Okely
School of Health and Society, University of Wollongong, Wollongong, Australia
1 shared publication Arash Akbarzad‐Yousefi
National Blood Service Newcastle‐upon‐Tyne Newcastle upon Tyne UK
1 shared publication- Arthi Anand
Histocompatibility and Immunogenetics Laboratory, Northwest London Pathology NHS Trust, Hammersmith Hospital, London, United Kingdom
1 shared publication - Billie Bonevski
Flinders Health and Medical Research Institute, College of Medicine and Public Health Flinders University Adelaide Australia
1 shared publication
Latest Publications
- 2 November 2023
- Published by Wiley in International Journal of Immunogenetics
- Vol. 50 (S2) , 3-63
BSHI and BTS UK guideline on the detection of alloantibodies in solid organ (and islet) transplantation
Solid organ transplantation represents the best (and in many cases only) treatment option for patients with end‐stage organ failure. The effectiveness and functioning life of these transplants has improved each decade due to surgical and clinical advances, and accurate histocompatibility assessment. Patient exposure to alloantigen from another individual is a common occurrence and takes place through pregnancies, blood transfusions or previous transplantation. Such exposure to alloantigen's can lead to the formation of circulating alloreactive antibodies which can be deleterious to solid organ transplant outcome. The purpose of these guidelines is to update to the previous BSHI/BTS guidelines 2016 on the relevance, assessment, and management of alloantibodies within solid organ transplantation.
- 2 November 2023
- Published by Wiley in International Journal of Immunogenetics
- Vol. 50 (S2) , 3-63
BSHI and BTS UK guideline on the detection of alloantibodies in solid organ (and islet) transplantation
Solid organ transplantation represents the best (and in many cases only) treatment option for patients with end‐stage organ failure. The effectiveness and functioning life of these transplants has improved each decade due to surgical and clinical advances, and accurate histocompatibility assessment. Patient exposure to alloantigen from another individual is a common occurrence and takes place through pregnancies, blood transfusions or previous transplantation. Such exposure to alloantigen's can lead to the formation of circulating alloreactive antibodies which can be deleterious to solid organ transplant outcome. The purpose of these guidelines is to update to the previous BSHI/BTS guidelines 2016 on the relevance, assessment, and management of alloantibodies within solid organ transplantation.
- Open Access
- 6 May 2022
- Published by Elsevier in Journal of Nutrition Education and Behavior
- Vol. 54 (5) , A1-A2
Table of Contents
- 6 May 2022
- Published by Elsevier in Journal of Nutrition Education and Behavior
- Vol. 54 (5) , A1-A2
Open AccessTable of Contents
- Open Access
- 8 April 2022
- Published by Ubiquity Press, Ltd. in International Journal of Integrated Care
- Vol. 22 (S1) , 6
Unpacking the Black Box of Medical Leadership in a Complex Specialist Rehabilitation Hospital: An Action Research Study. Phase 1: Preunderstanding
- 8 April 2022
- Published by Ubiquity Press, Ltd. in International Journal of Integrated Care
- Vol. 22 (S1) , 6
Open AccessUnpacking the Black Box of Medical Leadership in a Complex Specialist Rehabilitation Hospital: An Action Research Study. Phase 1: Preunderstanding